Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
GSK PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,684319-   
Low Rs1,231230-   
Sales per share (Unadj.) Rs191.994.9-  
Earnings per share (Unadj.) Rs35.9-23.9-  
Cash flow per share (Unadj.) Rs39.8-19.8-  
Dividends per share (Unadj.) Rs32.000-  
Avg Dividend yield %2.20-  
Book value per share (Unadj.) Rs102.974.5-  
Shares outstanding (eoy) m169.41168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.62.9 262.4%   
Avg P/E ratio x40.6-11.5 -353.8%  
P/CF ratio (eoy) x36.7-13.9 -264.6%  
Price / Book Value ratio x14.23.7 384.2%  
Dividend payout %89.20-   
Avg Mkt Cap Rs m246,85846,340 532.7%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m5,9502,908 204.6%   
Avg. sales/employee Rs Th03,730.7-  
Avg. wages/employee Rs Th0677.5-  
Avg. net profit/employee Rs Th0-940.1-  
INCOME DATA
Net Sales Rs m32,51716,016 203.0%  
Other income Rs m1,007112 897.5%   
Total revenues Rs m33,52416,128 207.9%   
Gross profit Rs m8,033-2,775 -289.4%  
Depreciation Rs m658691 95.1%   
Interest Rs m18434 4.2%   
Profit before tax Rs m8,364-3,788 -220.8%   
Minority Interest Rs m0-11 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,288237 966.4%   
Profit after tax Rs m6,076-4,036 -150.6%  
Gross profit margin %24.7-17.3 -142.6%  
Effective tax rate %27.4-6.2 -437.7%   
Net profit margin %18.7-25.2 -74.2%  
BALANCE SHEET DATA
Current assets Rs m24,94311,730 212.6%   
Current liabilities Rs m13,2646,600 201.0%   
Net working cap to sales %35.932.0 112.1%  
Current ratio x1.91.8 105.8%  
Inventory Days Days97111 87.7%  
Debtors Days Days216124 174.2%  
Net fixed assets Rs m6,9886,838 102.2%   
Share capital Rs m1,69474 2,278.2%   
"Free" reserves Rs m15,7350-   
Net worth Rs m17,43012,571 138.7%   
Long term debt Rs m04,418 0.0%   
Total assets Rs m31,93023,747 134.5%  
Interest coverage x462.6-7.7 -5,982.6%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.00.7 151.0%   
Return on assets %19.1-15.2 -125.8%  
Return on equity %34.9-32.1 -108.6%  
Return on capital %48.1-19.8 -242.8%  
Exports to sales %00-   
Imports to sales %48.10-   
Net fx Rs m-14,0080-   
CASH FLOW
From Operations Rs m4,8421,367 354.2%  
From Investments Rs m8,079-420 -1,924.6%  
From Financial Activity Rs m-15,4334,009 -384.9%  
Net Cashflow Rs m-2,5124,957 -50.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.4 Rs / ZAR

Compare GSK PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: SANOFI INDIA  CONCORD BIOTECH  AAYUSH FOOD & HERBS   EMMESSAR CHM  LASA SUPERGENERICS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.